DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

Referenz

Melcher CA, Janni W, Rack B et al.
DETECT III – a multicenter, randomized, phase III study to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells.

Eur J Cancer 2012;
48: S95-S96

Bibliographische Angaben herunterladen

Suchen in: